Medtox Scientific, Inc. (MTOX) Misses Q3 EPS by 2c, Sales Fall Short
Tweet
Share
E-mailGet Alerts MTOX Hot Sheet
Join SI Premium – FREE
Medtox Scientific, Inc. (NASDAQ: MTOX) reported Q3 EPS of $0.15, $0.02 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $27.6 million versus the consensus estimate of $28.58 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- Minerals Technologies (MTX) Tops Q1 EPS by 16c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
